- Home
- NUS vs CION Comparison
NUS vs CION Comparison
Compare NUS & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUS | CION |
|---|---|---|
| Founded | 1984 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.0M | 464.0M |
| IPO Year | 1996 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NUS | CION |
|---|---|---|
| Price | $7.13 | $6.55 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 575.2K | 565.3K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | 3.38% | ★ 17.34% |
| EPS Growth | ★ 207.80 | N/A |
| EPS | ★ 3.18 | N/A |
| Revenue | ★ $3,176,718,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | ★ $2.24 | $17.55 |
| Revenue Growth | ★ 48.98 | N/A |
| 52 Week Low | $5.32 | $6.92 |
| 52 Week High | $14.62 | $11.24 |
Technical Indicators
Market Signals| Indicator | NUS | CION |
|---|---|---|
| Relative Strength Index (RSI) | 23.76 | 11.69 |
| Support Level | N/A | N/A |
| Resistance Level | $11.06 | $10.17 |
| Average True Range (ATR) | 0.29 | 0.27 |
| MACD | -0.04 | -0.12 |
| Stochastic Oscillator | 5.74 | 0.76 |
Price Performance
Historical ComparisonAbout NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.